The company’s share price fell more than 5 points to 189.82 on Friday morning and have only marginally started climbing back. It marks a 2.52 per cent loss for CSL at the last close. CSL exports ...

D.D. Lewis, a former Dallas Cowboys linebacker who was on the team for their two Super Bowl championship seasons in 1971 and 1977, has died, the team announced. He was 79. Lewis was a Cowboys lifer – ...

CSL has partnered with Dutch biotech VarmX to co-develop VMX-C001, a potential first-in-class treatment to restore blood coagulation in patients on FXa inhibitors. The agreement includes an upfront ...

CSL pays $117 million for exclusive option to acquire VarmX VarmX could receive up to $388 million if milestones are met CSL funds VarmX's Phase 3 trial for VMX-C001 Sept 16 (Reuters) - Australia's ...

Exclusive option agreement for CSL to acquire all issued and outstanding shares of the company, dependent on Phase 3 data LEIDEN, Netherlands, September 16, 2025--(BUSINESS WIRE)--VarmX, a biotech ...

Full funding of VMX-C001 Phase 3 trial, late-stage product development, manufacturing and pre-launch activities VarmX shareholders to receive initial $117m upfront and further potential milestone ...

CSL will invest up to $760 million in Dutch biotech VarmX, marking the healthcare giant’s first major investment since it announced 3000 job cuts and plans to scale back its global research and ...

Cochin University of Science and Technology (Cusat) and Cochin Shipyard Limited (CSL) have signed a memorandum of understanding (MoU) to establish a centre of excellence in sustainable shipbuilding ...

Australia's largest biotech firm has joined a growing chorus of business leaders slamming a growing work-from-home culture amid plummeting productivity. Chairman Brian McNamee revealed there was ...

At a time when the nation’s chattering classes and business community are focusing on improving productivity and innovation, what’s one of the country’s few global brands in innovative high-tech ...

Nearly 15 per cent of CSL’s global workforce will be reduced in the biggest shake-up of the company in decades aimed at “simplifying the business”. CSL employs about 30,000 staff globally. Its share ...

Melbourne-headquartered CSL, a global biotechnology business specialising in bloods, vaccines and plasma products, on Tuesday revealed it will slash about 15 per cent of its staff in a sweeping ...